May 13, 2025 09:42AM
May 13, 2025 09:35AM
May 12, 2025 06:03AM
Apr 14, 2025 05:01PM
Jul 19, 2024 05:13PM
Jul 12, 2024 04:31PM
Jun 10, 2024 06:03AM Form S-1 CNS Pharmaceuticals,
Jan 30, 2024 05:48AM
Jan 29, 2024 09:00PM
Jan 22, 2024 06:03AM
Jan 10, 2024 05:27PM
Dec 8, 2023 05:28PM
Nov 30, 2022 10:00PM
Nov 28, 2022 08:31AM Form S-1/A CNS Pharmaceuticals,
Nov 15, 2022 04:52PM
Oct 21, 2022 05:02PM
Dec 23, 2020 08:33AM
Dec 23, 2020 08:30AM
Dec 22, 2020 08:33AM
Dec 21, 2020 08:39AM
Oct 12, 2020 08:00AM CNS Pharmaceuticals Highlights New Balancing Act Segment on Glioblastoma Airing on Lifetime TV
Oct 1, 2020 08:00AM
Sep 25, 2020 05:01PM
Jun 30, 2020 08:00AM
May 28, 2020 08:00AM
Apr 13, 2020 08:00AM
Mar 23, 2020 08:00AM
Mar 12, 2020 04:05PM CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
Mar 3, 2020 08:00AM
Feb 27, 2020 08:00AM
Feb 11, 2020 08:00AM
Feb 4, 2020 08:00AM
Jan 28, 2020 08:00AM
Jan 14, 2020 08:00AM
Jan 13, 2020 08:08AM CNS Pharmaceuticals (CNSP) Licenses Breakthrough Technology from MD Anderson
Jan 13, 2020 08:00AM
Dec 17, 2019 08:00AM
Dec 11, 2019 08:04AM
Dec 11, 2019 08:00AM
Dec 10, 2019 08:03AM
Dec 10, 2019 08:00AM
Nov 26, 2019 08:00AM CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
Nov 21, 2019 05:31PM
Nov 21, 2019 08:36AM
Nov 21, 2019 08:00AM
Nov 20, 2019 08:00AM
Nov 19, 2019 08:01AM
Nov 19, 2019 08:00AM
Nov 13, 2019 04:15PM CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock

66,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All